Selexis CHO Cells in Suspension-1

Archives 2012

Selexis has been setting the pace of innovation in protein expression and establishing new benchmarks in bioproduction for  two decades.

OCTOBER 3, 2012
1 min read

Selexis CSO to Speak at the Irvine Scientific Exhibit at BPI 2012

Dr. Pierre-Alain Girod Will Present Data on Achieving High Yields with Difficult-to-Express Proteins Using the Selexis...

Read More
JUNE 27, 2012
2 min read

Selexis Lubris Partnership Advances Difficult-to-Express Protein Towards Clinic

Lubris Achieves Over Gram per Liter of Recombinant Human Lubricin Using Selexis SUREtechnology Platform

Geneva,...

Read More
JUNE 6, 2012
2 min read

Irvine Scientific Launches BalanCD CHO SLX A Culture Media Developed for the Selexis SURE CHO-M Cell Line

The New Media Improves SURE CHO-M Productivity

Geneva, Switzerland, June 6, 2012 – Selexis SA, a global life sciences...

Read More
MAY 30, 2012
1 min read

Selexis SA to Partner and Exhibit at BIO 2012 in Boston MA

Selexis to Meet with Companies Interested in Mammalian Cell Line Development, Lead Identification for Therapeutic Drug...

Read More
MAY 29, 2012
1 min read

Selexis Co-Founder to Deliver Keynote Presentation at the 8th Annual Cell Line Development & Engineering Conference in San Francisco

Selexis to Meet with Companies Interested in Mammalian Cell Line Development, Lead Identification for Therapeutic Drug...

Read More
MAY 23, 2012
2 min read

Selexis SA and Fusion Antibodies Services Form Partnership to Speed Therapeutic Monoclonal Antibody Development

Geneva, Switzerland, May 23, 2012 (PRNewswire) – Selexis SA, a global life sciences company for drug discovery, cell...

Read More
MAY 15, 2012
1 min read

ADIENNE Pharma & Biotech Signs Service Agreement with Selexis for the Development of a Novel Fully Human Mini-Antibody

Geneva, Switzerland, May 15, 2012 (PRNewswire) – Selexis SA, a global life sciences company for drug discovery, cell...

Read More
APRIL 27, 2012
1 min read

Selexis to Speak on Designer CHO Cell Lines for Difficult-to-Express Proteins at the 2012 Protein Engineering (PEGS) Summit

Geneva, Switzerland (PRWEB) April 26, 2011 – Selexis SA, a global life sciences company for drug discovery, cell line...

Read More
APRIL 19, 2012
1 min read

Selexis to Present at Cell Culture Engineering XIII

Geneva, Switzerland (PRWEB) April 19, 2012 – Selexis SA announced today the Company’s co-founder will present data on...

Read More
JANUARY 9, 2012
1 min read

Selexis SA Appoints Yemi Onakunle as Vice President of Strategic and Market Development

Former Diosynth and Lonza Executive Joins Expanding Leadership Team

Geneva, Switzerland (PRWEB) January 6, 2012 –...

Read More
JANUARY 5, 2012
1 min read

Selexis SA to Present at Biotech Showcase 2012

Dr. Igor Fisch to Present in the Private Company Track

Geneva, Switzerland (PRWEB) January 5, 2012 – Selexis SA...

Read More